Interaction of powers in the Philippine presidential system

The executive - legislative relations in the Philippines have been described in two contrasting stories, namely the "strong president" story, and the "strong congress" story. This paper tries to consolidate the existing arguments and propose a new perspective focusing on the "compromise exchange" between the president and the congress across the different policy areas. It considers that the policy outcome is not brought by unilateral power of the president or the congress, but formed as the product of such an exchange. Interaction of powers and their complementary function are addressed. Furthermore, aside from the constitutional power, the weak party discipline is pointed out as a key factor in making the exchange possible.

Mathematical model for manoeuvrability of a riverine support patrol vessel with a pump-jet propulsion system

A study on the manoeuvrability of a riverine support patrol vessel is made to derive a mathematical model and simulate maneuvers with this ship. The vessel is mainly characterized by both its wide-beam and the unconventional propulsion system, that is, a pump-jet type azimuthal propulsion. By processing experimental data and the ship characteristics with diverse formulae to find the proper hydrodynamic coefficients and propulsion forces, a system of three differential equations is completed and tuned to carry out simulations of the turning test. The simulation is able to accept variable speed, jet angle and water depth as input parameters and its output consists of time series of the state variables and a plot of the simulated path and heading of the ship during the maneuver. Thanks to the data of full-scale trials previously performed with the studied vessel, a process of validation was made, which shows a good fit between simulated and full-scale experimental results, especially on the turning diameter

Powers in the Lucas sequence when the index is divisible by three

In this paper the m-powers with m ≥ 2 included in the Lucas sequences when the index satisfies some conditions are found

A Precharge-Absorbed DPL Logic for Reducing Early Propagation Effects on FPGA Implementations

In this paper, a new countermeasure against power and electromagnetic (EM) Side Channel Attacks (SCA) on FPGA implemented cryptographic algorithms is proposed. This structure mainly focuses on a critical vulnerability, Early Evaluation, also known as Early Propagation Effect (EPE), which exists in most conventional SCA-hardened DPL (Dual-rail with Precharge Logic) solutions. The main merit of this proposal is that the EPE can be effectively prevented by using a synchronized non regular precharge network, which maintains identical routing between the original and mirror parts, where costs and design complexity compared with previous EPE-resistant countermeasures are reduced, while security level is not sacrificed. Another advantage for our Precharge Absorbed(PA) - DPL method is that its Dual-Core style (independent architecture for true and false parts) could be generated using partial reconfiguration. This helps to get a dynamic security protection with better energy planning. That means system only keeps the true part which fulfills the normal en/decryption task in low security level, and reconfigures the false parts once high security level is required. A relatively limited clock speed is a compromise, since signal propagation is restricted to a portion of the clock period. In this paper, we explain the principles of PA-DPL and provide the guidelines to design this structure. We experimentally validate our methods in a minimized AES co-processor on Xilinx Virtex-5 board using electromagnetic (EM) attacks.

Direct-Drive Shock-Ignition for the Laser Megajoule.

We present a review of direct-drive shock ignition studies done as alternative for the Laser Mega-Joule to achieve high thermonuclear gain. One-dimensional analysis of HiPER-like Shock-ignited target designs is presented. It is shown that high gain can be achieved with shock ignition for designs which do not ignite only from the laser compression. Shock ignition is achieved for different targets of the fast ignition family which are driven by an absorbed energy between 100 kJ and 850kJ and deliver thermonuclear energies between 10-130 MJ. Shock-Ignition of Direct-Drive Double-Shell non-cryogenic target is also addressed. 2D results concerning the LMJ irradiation geometry are presented. Few systematic analyses are performed for the fuel assembly irradiation uniformity using the whole LMJ configuration or a part of the facility, and for the ignitor spike uniformity. Solutions for fuel assembly and shock ignition on LMJ using 2D calculations are presented. It is shown that high-gain shock-ignition is possible with intensity of each quad less than 1e15 W/cm2but low modes asymmetries displace the ignitor power in the spike towards higher powers.

EPIC (Entorno de Páncreas Artificial con Interfaz Clínica)

La Diabetes Mellitus se define como el trastorno del metabolismo de los carbohidratos, resultante de una producción insuficiente o nula de insulina en las células beta del páncreas, o la manifestación de una sensibilidad reducida a la insulina por parte del sistema metabólico. La diabetes tipo 1 se caracteriza por la nula producción de insulina por la destrucción de las células beta del páncreas. Si no hay insulina en el torrente sanguíneo, la glucosa no puede ser absorbida por las células, produciéndose un estado de hiperglucemia en el paciente, que a medio y largo plazo si no es tratado puede ocasionar severas enfermedades, conocidos como síndromes de la diabetes. La diabetes tipo 1 es una enfermedad incurable pero controlable. La terapia para esta enfermedad consiste en la aplicación exógena de insulina con el objetivo de mantener el nivel de glucosa en sangre dentro de los límites normales. Dentro de las múltiples formas de aplicación de la insulina, en este proyecto se usará una bomba de infusión, que unida a un sensor subcutáneo de glucosa permitirá crear un lazo de control autónomo que regule la cantidad optima de insulina aplicada en cada momento. Cuando el algoritmo de control se utiliza en un sistema digital, junto con el sensor subcutáneo y bomba de infusión subcutánea, se conoce como páncreas artificial endocrino (PAE) de uso ambulatorio, hoy día todavía en fase de investigación. Estos algoritmos de control metabólico deben de ser evaluados en simulación para asegurar la integridad física de los pacientes, por lo que es necesario diseñar un sistema de simulación mediante el cual asegure la fiabilidad del PAE. Este sistema de simulación conecta los algoritmos con modelos metabólicos matemáticos para obtener una visión previa de su funcionamiento. En este escenario se diseñó DIABSIM, una herramienta desarrollada en LabViewTM, que posteriormente se trasladó a MATLABTM, y basada en el modelo matemático compartimental propuesto por Hovorka, con la que poder simular y evaluar distintos tipos de terapias y reguladores en lazo cerrado. Para comprobar que estas terapias y reguladores funcionan, una vez simulados y evaluados, se tiene que pasar a la experimentación real a través de un protocolo de ensayo clínico real, como paso previo al PEA ambulatorio. Para poder gestionar este protocolo de ensayo clínico real para la verificación de los algoritmos de control, se creó una interfaz de usuario a través de una serie de funciones de simulación y evaluación de terapias con insulina realizadas con MATLABTM (GUI: Graphics User Interface), conocido como Entorno de Páncreas artificial con Interfaz Clínica (EPIC). EPIC ha sido ya utilizada en 10 ensayos clínicos de los que se han ido proponiendo posibles mejoras, ampliaciones y/o cambios. Este proyecto propone una versión mejorada de la interfaz de usuario EPIC propuesta en un proyecto anterior para gestionar un protocolo de ensayo clínico real para la verificación de algoritmos de control en un ambiente hospitalario muy controlado, además de estudiar la viabilidad de conectar el GUI con SimulinkTM (entorno gráfico de Matlab de simulación de sistemas) para su conexión con un nuevo simulador de pacientes aprobado por la JDRF (Juvenil Diabetes Research Foundation). SUMMARY The diabetes mellitus is a metabolic disorder of carbohydrates, as result of an insufficient or null production of insulin in the beta cellules of pancreas, or the manifestation of a reduced sensibility to the insulin from the metabolic system. The type 1 diabetes is characterized for a null production of insulin due to destruction of the beta cellules. Without insulin in the bloodstream, glucose can’t be absorbed by the cellules, producing a hyperglycemia state in the patient and if pass a medium or long time and is not treated can cause severe disease like diabetes syndrome. The type 1 diabetes is an incurable disease but controllable one. The therapy for this disease consists on the exogenous insulin administration with the objective to maintain the glucose level in blood within the normal limits. For the insulin administration, in this project is used an infusion pump, that permit with a subcutaneous glucose sensor, create an autonomous control loop that regulate the optimal insulin amount apply in each moment. When the control algorithm is used in a digital system, with the subcutaneous senor and infusion subcutaneous pump, is named as “Artificial Endocrine Pancreas” for ambulatory use, currently under investigate. These metabolic control algorithms should be evaluates in simulation for assure patients’ physical integrity, for this reason is necessary to design a simulation system that assure the reliability of PAE. This simulation system connects algorithms with metabolic mathematics models for get a previous vision of its performance. In this scenario was created DIABSIMTM, a tool developed in LabView, that later was converted to MATLABTM, and based in the compartmental mathematic model proposed by Hovorka that could simulate and evaluate several different types of therapy and regulators in closed loop. To check the performance of these therapies and regulators, when have been simulated and evaluated, will be necessary to pass to real experimentation through a protocol of real clinical test like previous step to ambulatory PEA. To manage this protocol was created an user interface through the simulation and evaluation functions od therapies with insulin realized with MATLABTM (GUI: Graphics User Interface), known as “Entorno de Páncreas artificial con Interfaz Clínica” (EPIC).EPIC have been used in 10 clinical tests which have been proposed improvements, adds and changes. This project proposes a best version of user interface EPIC proposed in another project for manage a real test clinical protocol for checking control algorithms in a controlled hospital environment and besides studying viability to connect the GUI with SimulinkTM (Matlab graphical environment in systems simulation) for its connection with a new patients simulator approved for the JDRF (Juvenil Diabetes Research Foundation).

Power absorption measurements during NMR experiments

The heating produced by the absorption of radiofrequency (RF) has been considered a secondary undesirable effect during MRI procedures. In this work, we have measured the power absorbed by distilled water, glycerol and egg-albumin during NMR and non-NMR experiments. The samples are dielectric and examples of different biological materials. The samples were irradiated using the same RF pulse sequence, whilst the magnetic field strength was the variable to be changed in the experiments. The measurements show a smooth increase of the thermal power as the magnetic field grows due to the magnetoresistive effect in the copper antenna, a coil around the probe, which is directly heating the sample. However, in the cases when the magnetic field was the adequate for the NMR to take place, some anomalies in the expected thermal powers were observed: the thermal power was higher in the cases of water and glycerol, and lower in the case of albumin. An ANOVA test demonstrated that the observed differences between the measured power and the expected power are significant.

Bacteria lacking a multidrug pump: A sensitive tool for drug discovery

Microorganisms express multidrug resistance pumps (MDRs) that can confound antibiotic discovery. We propose the use of mutants deficient in MDRs to overcome this problem. Sensitivity to quinolones and to amphipathic cations (norfloxacin, benzalkonium chloride, cetrimide, pentamidine, etc.) was increased 5- to 30-fold in a Staphylococcus aureus mutant with a disrupted chromosomal copy of the NorA MDR. NorA was required both for increased sensitivity to drugs in the presence of an MDR inhibitor and for increased rate of cation efflux. This requirement suggests that NorA is the major MDR protecting S. aureus from the antimicrobials studied. A 15- to 60-fold increase in sensitivity to antimicrobials also was observed in wild-type cells at an alkaline pH that favors accumulation of cations and weak bases. This effect was synergistic with a norA mutation, resulting in an increase up to 1,000-fold in sensitivity to antimicrobials. The usefulness of applying MDR mutants for natural product screening was demonstrated further by increased sensitivity of the norA− strain to plant alkaloid antimicrobials, which might be natural MDR substrates.

The medial-Golgi Ion Pump Pmr1 Supplies the Yeast Secretory Pathway with Ca2+ and Mn2+ Required for Glycosylation, Sorting, and Endoplasmic Reticulum-Associated Protein Degradation

The yeast Ca2+ adenosine triphosphatase Pmr1, located in medial-Golgi, has been implicated in intracellular transport of Ca2+ and Mn2+ ions. We show here that addition of Mn2+ greatly alleviates defects of pmr1 mutants in N-linked and O-linked protein glycosylation. In contrast, accurate sorting of carboxypeptidase Y (CpY) to the vacuole requires a sufficient supply of intralumenal Ca2+. Most remarkably, pmr1 mutants are also unable to degrade CpY*, a misfolded soluble endoplasmic reticulum protein, and display phenotypes similar to mutants defective in the stress response to malfolded endoplasmic reticulum proteins. Growth inhibition of pmr1 mutants on Ca2+-deficient media is overcome by expression of other Ca2+ pumps, including a SERCA-type Ca2+ adenosine triphosphatase from rabbit, or by Vps10, a sorting receptor guiding non-native luminal proteins to the vacuole. Our analysis corroborates the dual function of Pmr1 in Ca2+ and Mn2+ transport and establishes a novel role of this secretory pathway pump in endoplasmic reticulum-associated processes.

Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor

Multidrug resistance pumps (MDRs) protect microbial cells from both synthetic and natural antimicrobials. Amphipathic cations are preferred substrates of MDRs. Berberine alkaloids, which are cationic antimicrobials produced by a variety of plants, are readily extruded by MDRs. Several Berberis medicinal plants producing berberine were found also to synthesize an inhibitor of the NorA MDR pump of a human pathogen Staphylococcus aureus. The inhibitor was identified as 5′-methoxyhydnocarpin (5′-MHC), previously reported as a minor component of chaulmoogra oil, a traditional therapy for leprosy. 5′-MHC is an amphipathic weak acid and is distinctly different from the cationic substrates of NorA. 5′-MHC had no antimicrobial activity alone but strongly potentiated the action of berberine and other NorA substrates against S. aureus. MDR-dependent efflux of ethidium bromide and berberine from S. aureus cells was completely inhibited by 5′-MHC. The level of accumulation of berberine in the cells was increased strongly in the presence of 5′-MHC, indicating that this plant compound effectively disabled the bacterial resistance mechanism against the berberine antimicrobial.